SecBot SecBot
3 ·Filed Nov 3, 2026

MGNX

MACROGENICS INC
NEUTRAL
Impact 1/10
Horizonimmediate Processed13d 10h ago SEC0001892413-26-000013
Form 3: initial insider ownership statement
Actionable Insight • Neutral

This is a routine initial ownership filing for a new insider. No trading activity or change in beneficial ownership is indicated. Monitor future Form 4 filings for any subsequent transactions by Kuriakose.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$2.31
T+0 close · Nov 3, 2026 · via day close
Latest settled
+0.43%
T+5 · $2.32 · next T+20 in 16d
Vs SPY
+1.35%
α at T+5
Latest observation
−4.14%
T+7 · FF3 residual α
  1. T+0 · Nov 4 $2.31entry
  2. T+1 · 12d ago −3.90%α +0.51% · $2.22
  3. T+5 · 6d ago +0.43%α +1.35% · $2.32
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Emil Kuriakose filed a Form 3 initial statement of beneficial ownership with MacroGenics Inc, reporting no securities beneficially owned. The filing also includes a limited power of attorney authorizing James Karrels, Jeffrey Peters, and Beth Smith to execute Section 16 filings on his behalf. This is a routine administrative filing with no material financial impact.

Key Facts

  • Emil Kuriakose filed a Form 3 initial statement of beneficial ownership with MacroGenics Inc
  • The filing reports 0 shares beneficially owned by Kuriakose
  • A limited power of attorney was executed authorizing James Karrels, Jeffrey Peters, and Beth Smith to handle Section 16 filings
  • The Form 3 was signed by Beth A. Smith as attorney-in-fact on 2026-11-03

Financial Impact

No financial impact; no securities reported owned

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
64% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001892413-26-000013
Document: 0001892413-26-000013-index-headers.html0001892413-26-000013
Document: 0001892413-26-000013-index.html0001892413-26-000013
Document: 0001892413-26-000013.txt0001892413-26-000013

Track record

21 reports on MGNX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +130.41% at T+60 after the Feb 28, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $2.22 Now $2.17 −2.25% settles Feb 12
  2. Nov 13, 20263d ago 8-K Neutral 4/10 Entry $2.31 Now $2.17 −6.06% settles Feb 12
  3. Nov 12, 20264d ago Press Release Bearish 5/10 Entry $2.20 Now $2.17 +1.36% settles Feb 11
  4. Nov 3, 202613d ago 3 Neutral 1/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
  5. Nov 3, 202613d ago 3 Neutral 1/10 Viewing Entry $2.31 Now $2.17 −6.06% settles Feb 2
  6. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $2.31 Now $2.17 −6.06% settles Feb 2
  7. Oct 26, 202621d ago Press Release Bullish 6/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
  8. Oct 23, 202624d ago 8-K Bullish 7/10 Entry $2.19 Now $2.17 −0.91% settles Jan 22
  9. Oct 22, 202625d ago 144 Neutral 2/10 Entry $2.25 Now $2.17 −3.56% settles Jan 21
  10. Oct 15, 20264w ago Press Release Neutral 3/10 Entry $3.25 Now $2.17 −33.23% settles Jan 13
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026